Cargando…

Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies

The Chimeric antigen receptor (CAR)-T cell therapy has made inroads in treating hematological malignancies. Nonetheless, there are still multiple hurdles in CAR-T cell therapy for solid tumors. Primary CAR-expressing macrophage cells (CAR-Ms) and induced pluripotent stem cells (iPSCs)-derived CAR-ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Siyu, Lei, Anhua, Wang, Xudong, Lu, Hengxing, Wang, Shuhang, Yang, Yuqi, Li, Ning, Zhang, Yi, Zhang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139529/ https://www.ncbi.nlm.nih.gov/pubmed/35626689 http://dx.doi.org/10.3390/cells11101652

Ejemplares similares

CAR-macrophage: An extensive immune enhancer to fight cancer
por: Wang, Shuhang, et al.
Publicado: (2022)

Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors
por: Wang, Xudong, et al.
Publicado: (2023)

DAMPs released by pyroptotic cells as major contributors and therapeutic targets for CAR-T-related toxicities
por: Deng, Tian, et al.
Publicado: (2021)

CAR‐NK cells from engineered pluripotent stem cells: Off‐the‐shelf therapeutics for all patients
por: Lu, Shi‐Jiang, et al.
Publicado: (2021)

The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma
por: Wei, Jianshu, et al.
Publicado: (2020)

Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
por: Zhang, Li, et al.
Publicado: (2020)

Hunting field: insights on distribution pattern of bacteria and immune cells in solid tumors
por: Li, Yang, et al.
Publicado: (2021)

Clinical Investigations of CAR-T Cell Therapy for Solid Tumors
por: Chen, Kun, et al.
Publicado: (2022)

The tumor vasculature an attractive CAR T cell target in solid tumors
por: Akbari, Parvin, et al.
Publicado: (2019)

Harnessing the Gut Microbiota to Potentiate the Efficacy of CAR T Cell Therapy
por: Gabrielli, Giulia, et al.
Publicado: (2023)

CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
por: Liu, Maoxuan, et al.
Publicado: (2022)

CAR-T Cells in Canada; Perspective on How to Ensure We Get Our Value’s Worth
por: Villeneuve, Pierre J. A., et al.
Publicado: (2023)

The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
por: Ljungman, Per, et al.
Publicado: (2020)

Similarities and interplay between senescent cells and macrophages
por: Behmoaras, Jacques, et al.
Publicado: (2020)

Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era
por: Li, Jiakang, et al.
Publicado: (2022)

Microfluidic cell squeeze-based vaccine comes into clinical investigation
por: Wang, Shuhang, et al.
Publicado: (2023)

Ten-eleven translocation-2 affects the fate of cells and has therapeutic potential in digestive tumors
por: Wang, Feng, et al.
Publicado: (2020)

CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies
por: Abdin, Shifaa M., et al.
Publicado: (2021)

Lead Exposures from Car Batteries—A Global Problem
por: Fuller, Richard
Publicado: (2009)

Stem Cell‐Derived Extracellular Vesicles as a Novel Potential Therapeutic Tool for Tissue Repair
por: Chen, Bi, et al.
Publicado: (2017)

Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases
por: Kim, Seung Hyun, et al.
Publicado: (2018)

Rapid and efficient transfer of the T cell aging marker CD57 from glioblastoma stem cells to CAR T cells
por: Zhu, Xuekai, et al.
Publicado: (2015)

Cell-mediated immune resistance in cancer
por: Wang, Yuhao, et al.
Publicado: (2020)

ORAI1 Crac Channel in Immune Cell is a Therapeutic Target for Pancreatitis-Associated Acute Lung Injury
por: Peng, Shuang, et al.
Publicado: (2023)

Understanding the Mechanisms of Resistance to CAR T-Cell Therapy in Malignancies
por: Cheng, Jiali, et al.
Publicado: (2019)

Assuring quality health care outcomes: lessons learned from car dealers?
por: Dimsdale, Joel E
Publicado: (2017)

Therapeutic potential of stem cells in orthopedics
por: Bahney, Chelsea Shields, et al.
Publicado: (2012)

Cancer Stem Cells Therapeutic Target Database: The First Comprehensive Database for Therapeutic Targets of Cancer Stem Cells
por: Hu, Xiaoqing, et al.
Publicado: (2016)

Immune-mediated inflammatory disease therapeutics: past, present and future
por: McInnes, Iain B., et al.
Publicado: (2021)

The future of sickle cell disease therapeutics rests in genomics
por: Wonkam, Ambroise
Publicado: (2023)

Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids
por: Suraiya, Anisha B., et al.
Publicado: (2022)

Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies
por: Li, Yimei, et al.
Publicado: (2022)

Cell-targeting antibodies in immunity to Ebola
por: Schmaljohn, Alan, et al.
Publicado: (2016)

Calcium in Pancreatitis … Immune Cells, Too?
por: Vigna, Steven R, et al.
Publicado: (2020)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

The pharmacology and therapeutic role of cannabidiol in diabetes
por: Zhang, Jin, et al.
Publicado: (2023)

Free-cell therapeutics and mechanism of exosomes from adipose-derived stem cells in promoting wound healing: current understanding and future applications
por: Liu, Na, et al.
Publicado: (2022)

Defining cell types and states with single-cell genomics
por: Trapnell, Cole
Publicado: (2015)

The hospital exemption pathway for the approval of advanced therapy medicinal products: an underused opportunity? The case of the CAR-T ARI-0001
por: Trias, Esteve, et al.
Publicado: (2022)

Regulatory issues in stem cell therapeutics in Korea: efficacy or efficiency?
por: Oh, Il-Hoan
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_t37kvt0gh2f4kk15n1fp2qmlh0